Par Pharmaceutical Completes Acquisition Of Anchen

 11/17/2011 (RTTNews) - Par Pharmaceutical Companies, Inc. (PRX: News ) said Thursday that it has completed its acquisition of privately-held Anchen Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products. Headquartered in Irvine, California , Anchen is a profitable, fully-integrated pharmaceutical company with five commercialized products, 27 ANDAs on file with the US FDA, five of which are believed to be first-to-file, and about 26 additional products in development. Anchen has about 200 employees and over 72,000 sq. ft. of expandable manufacturing and warehouse facilities with state-of-the-art equipment. The $410 million purchase price was financed with cash on hand and a $350 million term loan.